Research Paper Volume 16, Issue 1 pp 872—910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Figure 2. Summary of relativity between survival prognosis across cancer types in TCGA dataset and XRCC1 gene expression levels. The GEPIA database was utilized to plot overall survival (A) and disease-free survival (B) conditions across cancer types in TCGA dataset by XRCC1 gene expression. We observed that high XRCC1 gene expression was related to worse OS and DFS in almost all cancer types, except DFS in UCEC cohorts(n=160) and THYM cohorts(n=118). Only p-values < 0.05 were displayed.